[Current anti-arrhythmic treatments and drugs].
D000200:Action Potentials; D000255:Adenosine Triphosphate / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000145:classification / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001572:Benzofurans / Q000627:therapeutic use; D001949:Bretylium Compounds / Q000627:therapeutic use; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004491:Edrophonium / Q000627:therapeutic use; D006801:Humans; D008012:Lidocaine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011299:Prenylamine / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D001572:Benzofurans; D001949:Bretylium Compounds; D004071:Digitalis Glycosides; D010672:Phenytoin; D004491:Edrophonium; D000255:Adenosine Triphosphate; D008012:Lidocaine; D011433:Propranolol; D014700:Verapamil; D011802:Quinidine; D011299:Prenylamine; D011342:Procainamide
Traitements et médicaments antiarythmiques actuels.